Prestige Multiple Critical Illness by Great Eastern Life

Prestige Multiple Critical Illness is a non-participating single-premium term plan from Great Eastern Life designed to provide financial protection against death and 36 critical illnesses. Unlike traditional annual term policies, this product requires a one-time lump-sum payment, with coverage lasting until the insured reaches age 80 (next birthday). The plan offers a level sum assured for critical illness claims, allowing up to 30 payouts for different conditions, subject to a 12-month waiting period between each claim. It also includes an additional benefit for angioplasty and other invasive treatments for coronary artery disease. As a pure protection product with no cash value or surrender value after the initial term, it is structured specifically for those seeking comprehensive critical illness coverage without ongoing premium obligations.

How it compares

The fundamental difference between Prestige Multiple Critical Illness and its peers lies in the payment structure and coverage duration. Prestige is a single-premium plan with a very long coverage term (up to 40+ years depending on entry age, extending to age 80), whereas competitors like PRUvital Cover, Singlife Essential Critical Illness II, and ManuProtect Term Lite are annual renewable or level premium term plans.

While the annualized cost of competitors like Singlife ($468) or PRUvital ($519) may appear lower in isolation, Prestige’s single premium ranges from $50,000 to $1,875,000 (average $509,000 across 25 quotes). This makes Prestige suitable for individuals with significant liquid capital who wish to lock in coverage without future payment risk. In contrast, the peer products require ongoing annual payments but offer lower entry costs and flexible term lengths. Prestige does not allow SRS or CPFIS premium payments, unlike some other market options that may permit these funding sources for annual premiums.

Pros

• Premium-Free Lifetime Coverage: The single premium structure eliminates the risk of future premium hikes or policy lapse due to non-payment, providing certainty until age 80.
• Extensive Critical Illness Payouts: Offers up to 30 claims for different critical illnesses, which is significantly higher than many standard CI plans that limit payouts to one or two.
• Comprehensive Coverage: Includes 36 critical illnesses aligned with LIA Version 2024 definitions and an additional benefit for coronary artery treatments.
• Strong Insurer Stability: Backed by Great Eastern Life, which holds an AA- credit rating from Standard & Poor’s, indicating high financial strength.

Cons

• High Upfront Cost: The single premium is substantial (avg $509,000), requiring significant immediate liquidity compared to annual premiums of competitors.
• No Cash Value or Investment Return: As a pure term product, there are no bonuses, investment components, or surrender values. If the policy is surrendered early, the value may be zero or less than the premium paid.
• Limited Flexibility in Payment Methods: Does not accept SRS or CPFIS funds for premium payment, limiting funding options for some consumers.
• Strict Claim Conditions: Heart-related critical illnesses are grouped (only one payout allowed among five specific heart conditions), and claims for Terminal Illness or Loss of Independent Existence are restricted to the first claim only.

Who it may suit

This product is best suited for high-net-worth individuals who have already maximized other investment avenues and possess a large lump sum they wish to allocate toward guaranteed critical illness protection. It appeals to those who want to avoid the hassle and risk of annual premium payments over several decades. It is less suitable for consumers seeking lower entry costs, those who prefer using SRS/CPFIS for insurance funding, or individuals who value cash value accumulation features found in participating or investment-linked plans.

This is general information based on CompareFIRST.sg data, not financial advice. Premiums and features can change; please verify with the insurer or a MAS-licensed financial adviser before making any decision.